Co-Diagnostics, a molecular diagnostics company, will release its third quarter 2026 financial results on November 12, 2026, after market close. The company will hold a conference call and webcast at 4:30 p.m. ET the same day to discuss the results with analysts. CEO Dwight Egan and EVP of Finance Daniel Bohrer will lead the call. This event provides investors an opportunity to hear directly from management about the company's financial performance and outlook.
Co-Diagnostics announces its third quarter 2026 earnings release date and webcast. For readers following the health sector, here is Pluang's market snapshot as of Oct 29, 2026 19:12 WIB: out of 150 priced health-sector US stocks, 91 rose and 53 fell. Notable movers include Novartis AG (NVS) at USD 161.10 with a 1-day change of +3.22% and Pluang order activity of 58% Sell / 42% Buy, Ionis Pharmaceuticals Inc. (IONS) at USD 46.31 with a 1-day change of +3.14%, and Amylx Pharmaceuticals Inc. (AMLX) at USD 28.94 with a 1-day change of +3.10%.
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...
Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
